Part: 12         Session: 145678910111213141516171819202122         Page 861862863864865866867868869870871872873874875876877878879880881882883884885886887888889890891892893894895896897898899900901902903904905906907908909910911912913914915916917918919920921922923924925926927928929930 of 999

diffused in his thinking and hard to understand because he talks in medical terms to people who are possible givers but can't understand him.

That's a bad thing.

It's very tough because he has to learn to talk in very simple language. However, they are still working on it, and I'm still interested in helping them.

And what is this FIBER committee

I think it's stimulated Butler and the Institute...

NIH.

Yes, I do think so, and the Institute on Aging is going to have a meeting in September, to which I'm going to go. And I'm actually taking one of the drugs they were interested in called Co-enzyme Q, which was discovered by Fokers, who was then at Merck. He left Merck shortly thereafter. It was never patented. He went to Japan; the Japanese took an interest in it. The Japanese use it. It's the third or fourth best selling drug in Japan, but it isn't sold here at all, and I'm trying to interest several drug firms in it. I don't, know whether I'll